Keyphrases
Clinical Application
100%
Antipsychotics
100%
Schizophrenia
37%
Relapse Prevention
25%
Acute Treatment
25%
Psychosis
25%
Metabolism
12%
Illness
12%
Psychiatry
12%
Unresolved Issues
12%
Rating Scales
12%
Drug Development
12%
Weight Gain
12%
Dose-response Curve
12%
Plasma Parameters
12%
Pharmacogenetics
12%
Sedation
12%
Objectively Measured
12%
Non-adherence
12%
Drug Trials
12%
Risperidone
12%
Atypical Antipsychotics
12%
Once-daily Dosing
12%
Acute Relapse
12%
Placebo Response
12%
Chlorpromazine
12%
Dopamine Receptor Antagonist
12%
Long-acting Injectable Formulation
12%
Dopamine Partial Agonist
12%
Neuroscience-based Nomenclature
12%
Drug Use Initiation
12%
Medicine and Dentistry
Side Effect
100%
Antipsychotic Drug
100%
Relapse Prevention
50%
Antipsychotic
50%
Effect Size
25%
Dose Response
25%
Pharmacogenetics
25%
Psychiatry
25%
Partial Agonist
25%
Placebo Effect
25%
Chlorpromazine
25%
Atypical Antipsychotics
25%
Risperidone
25%
Rating Scale
25%
Diseases
25%
Drug Screening
25%
Pharmacology, Toxicology and Pharmaceutical Science
Side Effect
100%
Antipsychotic Drug
100%
Antipsychotic
50%
Drug Screening
25%
Drug Development
25%
Pharmacogenetics
25%
Risperidone
25%
Atypical Antipsychotics
25%
Placebo
25%
Partial Agonist
25%
Chlorpromazine
25%
Neuroscience-Based Nomenclature
25%
Diseases
25%